Literature DB >> 34890803

Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.

Jiaxing Wang1, Duane D Miller1, Wei Li2.   

Abstract

Tubulin is an important cancer drug target. Compounds that bind at the colchicine site in tubulin have attracted significant interest as they are generally less affected by multidrug resistance than other potential drugs. Modeling is useful in understanding the interactions between tubulin and colchicine binding site inhibitors (CBSIs), but because the colchicine binding site contains two flexible loops whose conformations are highly ligand-dependent, modeling has its limitations. X-ray crystallography provides experimental pictures of tubulin-ligand interactions at this challenging colchicine site. Since 2004, when the first X-ray structure of tubulin in complex with N-deacetyl-N-(2-mercaptoacetyl)-colchicine (DAMA-colchicine) was published, many X-ray crystal structures have been reported for tubulin complexes involving the colchicine binding site. In this review, we summarize the crystal structures of tubulin in complexes with various CBSIs, aiming to facilitate the discovery of new generations of tubulin inhibitors.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colchicine-binding-site inhibitors; Tubulin; X-ray crystallography

Mesh:

Substances:

Year:  2021        PMID: 34890803      PMCID: PMC8901563          DOI: 10.1016/j.drudis.2021.12.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  138 in total

1.  Studying drug-tubulin interactions by X-ray crystallography.

Authors:  Audrey Dorleans; Marcel Knossow; Benoît Gigant
Journal:  Methods Mol Med       Date:  2007

Review 2.  How cryo-electron microscopy and X-ray crystallography complement each other.

Authors:  Hong-Wei Wang; Jia-Wei Wang
Journal:  Protein Sci       Date:  2016-09-07       Impact factor: 6.725

3.  Cardiovascular toxicity profiles of vascular-disrupting agents.

Authors:  Ishwaria M Subbiah; Daniel J Lenihan; Apostolia M Tsimberidou
Journal:  Oncologist       Date:  2011-07-08

4.  Purification and characterization of tubulin-tyrosine ligase from porcine brain.

Authors:  H Murofushi
Journal:  J Biochem       Date:  1980-03       Impact factor: 3.387

5.  Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.

Authors:  Mingxu Ma; Zhongpeng Ding; Shixiao Wang; Lingling Ma; Yuxi Wang; Lili Zhong; Zhongping Li; Jinliang Yang; Wenbao Li
Journal:  Bioorg Med Chem       Date:  2019-03-20       Impact factor: 3.641

6.  Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.

Authors:  Sylvie Ducki; David Rennison; Meiko Woo; Alexander Kendall; Jérémie Fournier Dit Chabert; Alan T McGown; Nicholas J Lawrence
Journal:  Bioorg Med Chem       Date:  2009-09-25       Impact factor: 3.641

Review 7.  Do beta-tubulin mutations have a role in resistance to chemotherapy?

Authors:  Helen K Berrieman; Michael J Lind; Lynn Cawkwell
Journal:  Lancet Oncol       Date:  2004-03       Impact factor: 41.316

8.  The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.

Authors:  Jianhong Yang; Wei Yan; Yamei Yu; Yuxi Wang; Tao Yang; Linlin Xue; Xue Yuan; Caofeng Long; Zuowei Liu; Xiaoxin Chen; Mengshi Hu; Li Zheng; Qiang Qiu; Heying Pei; Dan Li; Fang Wang; Peng Bai; Jiaolin Wen; Haoyu Ye; Lijuan Chen
Journal:  J Biol Chem       Date:  2018-04-24       Impact factor: 5.157

9.  Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties.

Authors:  Hao Chen; Shanshan Deng; Yuxi Wang; Najah Albadari; Gyanendra Kumar; Dejian Ma; Weimin Li; Stephen W White; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2020-01-07       Impact factor: 7.446

10.  Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency.

Authors:  Wan Seok Yang; Kenichi Shimada; Darnelle Delva; Milesh Patel; Egberamwen Ode; Rachid Skouta; Brent R Stockwell
Journal:  ACS Med Chem Lett       Date:  2011-10-31       Impact factor: 4.345

View more
  2 in total

1.  Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking.

Authors:  Samia A Elseginy; A Sofia F Oliveira; Deborah K Shoemark; Richard B Sessions
Journal:  RSC Med Chem       Date:  2022-05-18

2.  Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs.

Authors:  Gisele Barbosa; Luis Gabriel Valdivieso Gelves; Caroline Marques Xavier Costa; Lucas Silva Franco; João Alberto Lins de Lima; Cristiane Aparecida-Silva; John Douglas Teixeira; Claudia Dos Santos Mermelstein; Eliezer J Barreiro; Lidia Moreira Lima
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.